A team of researchers used resources at the Evanston, Ill.-based university’s International Institute for Nanotechnology to discover and deploy the lipid-nanoparticle technology that delivers mRNA into patients’ cells, according to a complaint filed Wednesday in the US District Court for the District of Delaware. A Moderna spokesperson said the company “is aware of the litigation and will defend ourselves against these claims.”
- Northwestern, seeking damages but no injunctive relief, alleges that Moderna’s ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.